RedHill Biopharma (RDHL) Free Cash Flow (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly Free Cash Flow of -$2.4 million for Q4 2022, up 83.7% year-over-year from -$1.3 million in Q4 2021, and up 59.69% quarter-over-quarter from -$6.0 million in Q3 2022.
RedHill Biopharma (RDHL) Free Cash Flow (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Free Cash Flow for 11 consecutive years, with -$2.4 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Free Cash Flow rose 83.7% year-over-year to -$2.4 million; the TTM figure through Dec 2023 stood at -$2.4 million (up 91.65% YoY), while the FY2025 annual figure was -$9.6 million, down 3.06% from the prior year.
- Free Cash Flow improved to -$2.4 million in Q4 2022 per RDHL's latest filing, from -$6.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$2.4 million in Q4 2022 and bottomed at -$19.0 million in Q3 2021.
- Historically, Free Cash Flow has averaged -$10.8 million across 5 years, with a median of -$9.9 million in 2018.
- Annual changes were most pronounced in 2021 — Free Cash Flow plunged 111.04% — and 2022, when it soared 83.7%.
- RedHill Biopharma's Free Cash Flow stood at -$8.2 million in 2018, then sank by 68.96% to -$13.8 million in 2019, then grew by 8.53% to -$12.7 million in 2020, then dropped by 17.38% to -$14.9 million in 2021, then jumped by 83.7% to -$2.4 million in 2022.
- Business Quant data shows RDHL's Free Cash Flow at -$2.4 million in Q4 2022, -$6.0 million in Q3 2022, and -$16.4 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2.42 Mn |
| Dec 31, 2022 | -2.42 Mn |
| Sep 30, 2022 | -6.01 Mn |
| Sep 30, 2022 | -6.01 Mn |
| Jun 30, 2022 | -16.42 Mn |
| Jun 30, 2022 | -16.42 Mn |
| Mar 31, 2022 | -4.14 Mn |
| Mar 31, 2022 | -4.14 Mn |
| Dec 31, 2021 | -14.86 Mn |
| Dec 31, 2021 | -14.86 Mn |
| Sep 30, 2021 | -19.00 Mn |
| Sep 30, 2021 | -19.00 Mn |
| Jun 30, 2021 | -18.90 Mn |
| Jun 30, 2021 | -18.90 Mn |
| Mar 31, 2021 | -12.18 Mn |
| Mar 31, 2021 | -12.18 Mn |
| Dec 31, 2020 | -12.66 Mn |
| Dec 31, 2020 | -12.66 Mn |
| Sep 30, 2020 | -9.01 Mn |
| Sep 30, 2020 | -9.01 Mn |